Theranexus is an innovative biopharmaceutical company that spun off from the French Alternative Energies and Atomic Energy Commission (CEA). It specializes in the treatment of rare central nervous system disorders and is a pioneer in the development of drug candidates targeting both neurons and glial cells.
Theranexus has a unique advanced therapy candidate identification and characterization platform focused on rare neurological disorders and an initial drug candidate in clinical development for Batten disease.
Company Details
- Employees
- 15
- Founded
- -
- Address
- 60, Avenue Rockefeller, Lyon,auvergne-Rhône-Alpes 69008,france
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- theranexus.com
- HQ
- Lyon, Auvergne-Rhône-Alpes
Theranexus Questions
Theranexus's website is theranexus.com
Theranexus's LinkedIn profile is https://fr.linkedin.com/company/theranexus
Theranexus has
15 employees.
View email and phone details for 15
employees at Theranexus.
Theranexus's industry is
Biotechnology Research
Theranexus's top competitors are
Phaxiam Therapeutics,
Bioaster,
Cellectis,
Ose Immunotherapeutics,
Transgene,
Adocia,
Maat Pharma,
Abivax,
Enyo Pharma,
Innate Pharma.
Theranexus's categories are Biotechnology Research
Theranexus's founding year is 2013
